Hives clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Longitudinal Observational Study of Patients Undergoing Therapy for IMISC
open to all eligible people
TARGET-DERM is a longitudinal, observational study of adult and pediatric patients being managed for Atopic Dermatitis and other Immune-Mediated Inflammatory Skin Conditions (IMISC) in usual clinical practice. TARGET-DERM will create a research registry of patients with IMISC within academic and community real-world practices in order to assess the safety and effectiveness of current and future therapies.
at UC Irvine UCSD
Our lead scientists for Hives research studies include Natasha Mesinkovska, MD Lawrence F Eichenfield, MD.
Last updated: